TP53 and colorectal carcinoma: The correlation between THBS2 expression and clinical features in CRC patients was analyzed using UALCAN database according to age (Figure 2(b)), histological subtype (Figure 2(c)), gender (Figure 2(D)), node metastasis (Figure 2(e)), and TP53 mutation status (Figure 2(f)).